test

Sean Tan

@Stempoint Capital Lp

Latest period2024 - Q3ReportedManaged Assets$334.017MTotal holdings50
Assets growth rate-1.84%Assets growth rate (2-Q avg)-5.94%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Stempoint Capital Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 50 positions.

Assets under management

The assets under management (AUM) of Stempoint Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 334.017M in assets, with a quarterly growth rate of -1.84% and a 2-quarter average growth rate of -5.94%. The portfolio is managed by Sean Tan, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ACLXArcellx Inc
Recent Activity
Decreased -78.59%
1.51%
$5.017M
60,076 shares@ $83.52 avg price
VTGNVistagen Therapeutics Inc
Recent Activity
Decreased -0.09%
1.47%
$4.901M
1.847M shares@ $2.66 avg price
NRIXNurix Therapeutics Inc
Recent Activity
Decreased -0.12%
1.37%
$4.562M
203,015 shares@ $22.47 avg price
TCRXTscan Therapeutics Inc
Recent Activity
Increased 1.88%
1.29%
$4.288M
860,951 shares@ $4.99 avg price
ZURAZura Bio Ltd
Recent Activity
New Position
1.27%
$4.239M
1.044M shares@ $4.06 avg price
IDYAIdeaya Biosciences Inc
Recent Activity
Increased 30.38%
1.26%
$4.204M
132,703 shares@ $31.68 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
New Position
1.13%
$3.747M
449,321 shares@ $8.34 avg price
CATXPerspective Therapeutics Inc
Recent Activity
Decreased -30.75%
0.96%
$3.178M
238,084 shares@ $13.35 avg price
PYXSPyxis Oncology Inc
Recent Activity
Decreased -29.3%
0.94%
$3.12M
850,210 shares@ $3.68 avg price
NGNENeurogene Inc
Recent Activity
Decreased -6.74%
0.93%
$3.076M
73,299 shares@ $41.96 avg price